HYPER CORPORATION INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,480 KRW | +3.93% |
|
+13.85% | +50.56% |
| Sales 2019 | 17.41B 12.66M 17.34M | Sales 2020 | 31.41B 22.84M 31.29M | Capitalization | 148B 108M 148M |
|---|---|---|---|---|---|
| Net income 2019 | -1.78B -1.29M -1.77M | Net income 2020 | -3.52B -2.56M -3.51M | EV / Sales 2019 | 7.38 x |
| Net cash position 2019 | 9.93B 7.22M 9.89M | Net cash position 2020 | 10.9B 7.93M 10.86M | EV / Sales 2020 | 4.37 x |
| P/E ratio 2019 |
-78.3
x | P/E ratio 2020 |
-39.8
x | Employees | 33 |
| Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 81.64% |
More Fundamentals
* Assessed data
More news
| 1 day | +3.93% | ||
| 1 week | +13.85% | ||
| Current month | -1.33% | ||
| 1 month | -1.33% | ||
| 3 months | +52.42% | ||
| 6 months | +48.74% | ||
| Current year | +50.56% |
1 week
1 324.00
1 510.00
1 month
1 188.001 548.00
Current year
956.001 697.00
1 year
920.002 565.00
3 years
920.004 675.00
5 years
920.006 600.00
10 years
920.009 900.00
| Managers | Title | Age | Since |
|---|---|---|---|
Sang-Woo Kim
CEO | Chief Executive Officer | 51 | - |
Gwi-Yeon Moon
AUD | Comptroller/Controller/Auditor | 57 | - |
Sung-Joon Shin
PRN | Corporate Officer/Principal | 57 | 18-03-26 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sang-Woo Kim
CEO | Chief Executive Officer | 51 | - |
Se-Hoon Park
BRD | Director/Board Member | 52 | - |
Myung-Woo Lee
BRD | Director/Board Member | 42 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-30 | 1,480 | +3.93% | 690,974 |
| 24-04-29 | 1,424 | -1.45% | 895,636 |
| 24-04-26 | 1,445 | +3.29% | 553,607 |
| 24-04-25 | 1,399 | +3.63% | 562,722 |
| 24-04-24 | 1,350 | +0.60% | 338,371 |
End-of-day quote Korea S.E., April 29, 2024
More quotes
Medifron DBT Co., Ltd. is a Korea-based company mainly engaged in the production and sale of telecommunication equipments. The Company operates its business through two segments. The Information Technology Business segment is involved in the manufacturing and sale of mouses, monitors, televisions (TVs), routers and game devices. In addition, it is involved in the operation of Internet portals and specialized sites. The New Drug Business segment is engaged in the development and sale of non narcotic analgesics, Alzheimer's treatments, and Alzheimer's dementia diagnosis kits.
Sector
Computer Hardware
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +50.56% | 67.55M | |
| +55.27% | 84.78B | |
| -7.78% | 27.15B | |
| -3.18% | 21.37B | |
| +0.52% | 18.02B | |
| -16.76% | 14.16B | |
| -7.70% | 12.06B | |
| +7.01% | 9.84B | |
| +15.11% | 10.01B | |
| -12.16% | 9.81B |
- Stock Market
- Equities
- A065650 Stock
